No, No, No: (1) Copaxone (glatiramer) is an immunomodulator to limit your response to one multiple sclerosis antigen, not an immunosuppressant (2) the idea that "a strong immune system fights cancer" is a discredited notion, even dying aids patients have only slightly more of the common cancers; (3) if it did, nih research piranhas would have already noticed. Glad you're receiving this good rx -- and good luck.
Answered 11/12/2014
5.6k views
Probably not: The largest studies of long-term Copaxone (glatiramer) use do not show a significantly increased risk of cancers. However, there is a theoretical risk that decreasing the activity of the immune system could increase the chances of a cancer developing or growing more quickly. These concerns should be discussed with your neurologist so you can weigh this small risk against the benefits of this ms treatment.
Answered 11/12/2014
5.2k views
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
7 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question